Company Filing History:
1 out of 70 
1 out of 75 
Years Active: 2024
Title: Constanze Slabik: Innovator in Chimeric Antigen Receptor Technology
Introduction
Constanze Slabik is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of immunology, particularly in the development of chimeric antigen receptors (CARs) for therapeutic applications. Her innovative work focuses on targeting herpes virus antigens to improve treatment options for related medical disorders.
Latest Patents
Constanze Slabik holds a patent for a chimeric antigen receptor and CAR-T cells that bind a herpes virus antigen. The patent describes an isolated chimeric antigen receptor (CAR) polypeptide that includes an extracellular antigen-binding domain. This domain consists of an antibody or antibody fragment that binds to a protein encoded by a herpes virus. The invention is particularly relevant for treating medical disorders associated with human herpesvirus, such as herpes virus-associated cancers and chronic infections. The preferred target for the CAR is the Epstein-Barr virus glycoprotein 350/220.
Career Highlights
Throughout her career, Constanze has worked with esteemed institutions, including the Medical University of Hanover and the Helmholtz Center Munich, which is a leading research center for health and the environment. Her work has been instrumental in advancing the understanding and treatment of herpes virus-related conditions.
Collaborations
Constanze has collaborated with notable colleagues, including Renata Stripecke and Reinhard Zeidler. These partnerships have contributed to her research and the successful development of her patented technologies.
Conclusion
Constanze Slabik's innovative work in chimeric antigen receptor technology represents a significant advancement in the treatment of herpes virus-related medical disorders. Her contributions continue to influence the field of immunology and offer hope for improved therapeutic strategies.